• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分娩时输注了多少合成催产素?12 个国家使用方案的回顾与分析。

How much synthetic oxytocin is infused during labour? A review and analysis of regimens used in 12 countries.

机构信息

School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

NuMIQ research focus area: Research to promote quality of Nursing and Midwifery, North-West University, Potchefstroom, South Africa.

出版信息

PLoS One. 2020 Jul 28;15(7):e0227941. doi: 10.1371/journal.pone.0227941. eCollection 2020.

DOI:10.1371/journal.pone.0227941
PMID:32722667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7386656/
Abstract

OBJECTIVE

To compare synthetic oxytocin infusion regimens used during labour, calculate the International Units (IU) escalation rate and total amount of IU infused over eight hours.

DESIGN

Observational study.

SETTING

Twelve countries, eleven European and South Africa.

SAMPLE

National, regional or institutional-level regimens on oxytocin for induction and augmentation labour.

METHODS

Data on oxytocin IU dose, infusion fluid amount, start dose, escalation rate and maximum dose were collected. Values for each regimen were converted to IU in 1000ml diluent. One IU corresponded to 1.67μg for doses provided in grams/micrograms. IU hourly dose increase rates were based on escalation frequency. Cumulative doses and total IU amount infused were calculated by adding the dose administered for each previous hour. Main Outcome Measures Oxytocin IU dose infused.

RESULTS

Data were obtained on 21 regimens used in 12 countries. Details on the start dose, escalation interval, escalation rate and maximum dose infused were available from 16 regimens. Starting rates varied from 0.06 IU/hour to 0.90 IU/hour, and the maximum dose rate varied from 0.90 IU/hour to 3.60 IU/hour. The total amount of IU oxytocin infused, estimated over eight hours, ranged from 2.38 IU to 27.00 IU, a variation of 24.62 IU and an 11-fold difference.

CONCLUSION

Current variations in oxytocin regimens for induction and augmentation of labour are inexplicable. It is crucial that the appropriate minimum infusion regimen is administered because synthetic oxytocin is a potentially harmful medication with serious consequences for women and babies when inappropriately used. Estimating the total amount of oxytocin IU received by labouring women, alongside the institution's mode of birth and neonatal outcomes, may deepen our understanding and be the way forward to identifying the optimal infusion regimen.

摘要

目的

比较分娩时使用的合成催产素输注方案,计算国际单位 (IU) 递增率和 8 小时内输注的总 IU 量。

设计

观察性研究。

设置

12 个国家,11 个欧洲国家和南非。

样本

催产素用于引产和加强分娩的国家、地区或机构级方案。

方法

收集催产素 IU 剂量、输注液量、起始剂量、递增率和最大剂量的数据。每个方案的值均转换为 1000ml 稀释剂中的 IU。每 1IU 相当于提供的克/微克剂量的 1.67μg。IU 每小时剂量增加率基于递增频率。通过将前一小时给予的剂量相加来计算累积剂量和总 IU 量。

主要观察指标

输注的催产素 IU 剂量。

结果

在 12 个国家使用的 21 种方案中获得了数据。16 种方案提供了起始剂量、递增间隔、递增率和最大剂量输注的详细信息。起始率从 0.06IU/小时到 0.90IU/小时不等,最大剂量率从 0.90IU/小时到 3.60IU/小时不等。估计在 8 小时内输注的催产素 IU 总量从 2.38IU 到 27.00IU 不等,差异为 24.62IU,相差 11 倍。

结论

目前用于引产和加强分娩的催产素方案差异无法解释。至关重要的是,应给予适当的最低输注方案,因为合成催产素是一种潜在有害的药物,如果使用不当,会对妇女和婴儿造成严重后果。估计接受催产素的产妇接受的 IU 总量,以及机构的分娩模式和新生儿结局,可以加深我们的理解,并为确定最佳输注方案提供方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e92/7386656/d5761a2aa6e4/pone.0227941.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e92/7386656/cbac3e49b305/pone.0227941.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e92/7386656/d5761a2aa6e4/pone.0227941.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e92/7386656/cbac3e49b305/pone.0227941.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e92/7386656/d5761a2aa6e4/pone.0227941.g002.jpg

相似文献

1
How much synthetic oxytocin is infused during labour? A review and analysis of regimens used in 12 countries.分娩时输注了多少合成催产素?12 个国家使用方案的回顾与分析。
PLoS One. 2020 Jul 28;15(7):e0227941. doi: 10.1371/journal.pone.0227941. eCollection 2020.
2
Oxytocin administration for induction and augmentation of labour in polish maternity units - an observational study.催产素在波兰产科单位用于引产和加强产程的应用 - 一项观察性研究。
BMC Pregnancy Childbirth. 2021 Nov 11;21(1):764. doi: 10.1186/s12884-021-04190-w.
3
Misoprostol for induction of labour at term: a more effective agent than dinoprostone vaginal gel.米索前列醇用于足月引产:一种比地诺前列酮阴道凝胶更有效的药物。
Br J Obstet Gynaecol. 1999 Aug;106(8):793-7. doi: 10.1111/j.1471-0528.1999.tb08399.x.
4
High-dose compared with low-dose oxytocin for induction of labour of nulliparous women at term.足月未产妇引产时高剂量与低剂量缩宫素的比较。
J Matern Fetal Neonatal Med. 2019 Feb;32(3):362-368. doi: 10.1080/14767058.2017.1378338. Epub 2017 Sep 26.
5
Misoprostol for induction of labour: a systematic review.米索前列醇用于引产:一项系统评价。
Br J Obstet Gynaecol. 1999 Aug;106(8):798-803. doi: 10.1111/j.1471-0528.1999.tb08400.x.
6
High dose versus low dose oxytocin for augmentation of delayed labour.高剂量与低剂量缩宫素用于引产时产程延长的处理
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007201. doi: 10.1002/14651858.CD007201.pub2.
7
Inter-institutional variations in oxytocin augmentation during labour in German university hospitals: a national survey.德国大学医院分娩时催产素强化使用的机构间差异:一项全国性调查。
BMC Pregnancy Childbirth. 2019 Jul 9;19(1):238. doi: 10.1186/s12884-019-2348-x.
8
EFFECTIVENESS AND SAFETY OF 2-HOURLY 20 MCG ORAL MISOPROSTOL SOLUTION COMPARED TO STANDARD INTRAVENOUS OXYTOCIN IN LABOUR INDUCTION DUE TO PRE-LABOUR RUPTURE OF MEMBRANES AT TERM: A RANDOMISED CLINICAL TRIAL AT KENYATTA NATIONAL HOSPITAL.与标准静脉注射缩宫素相比,2小时一次20微克口服米索前列醇溶液用于足月胎膜早破引产的有效性和安全性:肯尼亚国家医院的一项随机临床试验
East Afr Med J. 2014 Sep;91(9):303-10.
9
A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction.阴道给予米索前列醇用于引产术前宫颈成熟和引产的不同给药方案比较。
Am J Obstet Gynecol. 1996 Jul;175(1):158-64. doi: 10.1016/s0002-9378(96)70267-3.
10
Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial.在产程活跃期继续或停止缩宫素输注:一项随机对照试验。
BJOG. 2016 Jan;123(1):129-35. doi: 10.1111/1471-0528.13589. Epub 2015 Aug 26.

引用本文的文献

1
Uterine Reaction to Oxytocin and Maternal-Neonatal Outcomes in Inducing Labor: A Retrospective Cohort Study.催产素引产时子宫反应与母婴结局:一项回顾性队列研究
Int J Womens Health. 2025 Aug 30;17:2793-2803. doi: 10.2147/IJWH.S532773. eCollection 2025.
2
Association between total oxytocin dose and maternal and neonatal morbidity during labour induction: a retrospective study.引产期间总缩宫素剂量与孕产妇及新生儿发病率之间的关联:一项回顾性研究。
BMC Pregnancy Childbirth. 2025 Aug 15;25(1):857. doi: 10.1186/s12884-025-08003-2.
3
Effect of preoperative oxytocin infusion on haemodynamics among women undergoing elective caesarean section under spinal anaesthesia: A randomised controlled study.

本文引用的文献

1
Maternal plasma levels of oxytocin during physiological childbirth - a systematic review with implications for uterine contractions and central actions of oxytocin.产妇在生理分娩过程中的血浆催产素水平——对子宫收缩和催产素的中枢作用的系统评价。
BMC Pregnancy Childbirth. 2019 Aug 9;19(1):285. doi: 10.1186/s12884-019-2365-9.
2
Inter-institutional variations in oxytocin augmentation during labour in German university hospitals: a national survey.德国大学医院分娩时催产素强化使用的机构间差异:一项全国性调查。
BMC Pregnancy Childbirth. 2019 Jul 9;19(1):238. doi: 10.1186/s12884-019-2348-x.
3
Discontinuation of intravenous oxytocin in the active phase of induced labour.
术前输注缩宫素对脊髓麻醉下行择期剖宫产术女性血流动力学的影响:一项随机对照研究。
Indian J Anaesth. 2025 Apr;69(4):343-349. doi: 10.4103/ija.ija_1062_24. Epub 2025 Mar 13.
4
Continuation versus discontinuation of intravenous oxytocin in the active phase of labour.分娩活跃期继续或停止静脉滴注催产素。
Cochrane Database Syst Rev. 2024 Nov 29;11(11):CD015995. doi: 10.1002/14651858.CD015995.
5
Oxytocin in growth, reproduction, restoration and health.催产素在生长、繁殖、恢复及健康方面的作用。
Compr Psychoneuroendocrinol. 2024 Sep 30;20:100268. doi: 10.1016/j.cpnec.2024.100268. eCollection 2024 Nov.
6
Is Oxytocin Induction at Labor a Risk Factor for Developmental Hip Dysplasia?分娩时催产素引产是发育性髋关节发育不良的危险因素吗?
J Clin Med. 2024 Sep 26;13(19):5724. doi: 10.3390/jcm13195724.
7
The Effect of Maternal Oxytocin Induction during Birth on Early Neonatal Pain and Stress: A Quasi-Experimental Study.分娩时母体催产素诱导对早期新生儿疼痛和应激的影响:一项准实验研究。
Biol Res Nurs. 2025 Jan;27(1):101-108. doi: 10.1177/10998004241289896. Epub 2024 Oct 6.
8
Maternal age and body mass index and risk of labor dystocia after spontaneous labor onset among nulliparous women: A clinical prediction model.产妇年龄、体重指数与初产妇自发临产分娩困难的风险:临床预测模型。
PLoS One. 2024 Sep 6;19(9):e0308018. doi: 10.1371/journal.pone.0308018. eCollection 2024.
9
Patterns of oxytocin use for induction and augmentation of labour among healthcare providers in Nigeria.尼日利亚医护人员在引产和加强产程中使用催产素的模式。
BMC Pregnancy Childbirth. 2024 Jun 1;24(1):403. doi: 10.1186/s12884-024-06593-x.
10
Physiological plateaus during normal labor and birth: A novel definition.正常分娩过程中的生理平台期:一种新定义。
Birth. 2025 Mar;52(1):55-65. doi: 10.1111/birt.12843. Epub 2024 May 27.
引产活跃期静脉滴注缩宫素的停用
Cochrane Database Syst Rev. 2018 Aug 20;8(8):CD012274. doi: 10.1002/14651858.CD012274.pub2.
4
Trends in perinatal health in metropolitan France from 1995 to 2016: Results from the French National Perinatal Surveys.1995年至2016年法国大都市围产期健康趋势:法国国家围产期调查结果
J Gynecol Obstet Hum Reprod. 2017 Dec;46(10):701-713. doi: 10.1016/j.jogoh.2017.09.002. Epub 2017 Oct 11.
5
Induction of labour practices in New South Wales hospitals: Before and after a statewide policy.
Aust N Z J Obstet Gynaecol. 2017 Feb;57(1):111-114. doi: 10.1111/ajo.12575.
6
Association of peripartum synthetic oxytocin administration and depressive and anxiety disorders within the first postpartum year.分娩期间使用合成缩宫素与产后第一年的抑郁和焦虑障碍之间的关联。
Depress Anxiety. 2017 Feb;34(2):137-146. doi: 10.1002/da.22599.
7
Lactate in Amniotic Fluid: Predictor of Labor Outcome in Oxytocin-Augmented Primiparas' Deliveries.羊水乳酸:缩宫素增强分娩初产妇分娩结局的预测指标
PLoS One. 2016 Oct 26;11(10):e0161546. doi: 10.1371/journal.pone.0161546. eCollection 2016.
8
Drivers of maternity care in high-income countries: can health systems support woman-centred care?高收入国家的孕产护理推动因素:卫生系统能否支持以妇女为中心的护理?
Lancet. 2016 Nov 5;388(10057):2282-2295. doi: 10.1016/S0140-6736(16)31527-6. Epub 2016 Sep 16.
9
Beyond too little, too late and too much, too soon: a pathway towards evidence-based, respectful maternity care worldwide.超越过少、过晚、过多、过快:迈向全球循证且尊重的母婴照护之路。
Lancet. 2016 Oct 29;388(10056):2176-2192. doi: 10.1016/S0140-6736(16)31472-6. Epub 2016 Sep 16.
10
Titration of intravenous synthetic oxytocin post vaginal birth following induction or augmentation.静脉注射合成催产素滴定法在诱导或加强阴道分娩后。
Sex Reprod Healthc. 2016 Oct;9:35-7. doi: 10.1016/j.srhc.2016.06.002. Epub 2016 Jun 24.